A 52-year-old man with newly diagnosed multiple myeloma (ISS stage II) is being initiated on chemotherapy. He has normal renal function (eGFR 85 mL/min/1.73m²), no prior malignancy, and is otherwise fit. The oncologist plans to use melphalan as part of the induction regimen. Before starting melphalan, what is the most appropriate immediate next step?